We are delighted to announce our society’s highest recognition, acknowledging outstanding and sustainable achievements in our field.
Find out more and nominate your colleagues today!
The ESOT Legacy Award 2025
Category: All
ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care
Our latest publication is a position paper from the ESOT Advanced Therapy Medicinal Products (ATMP) task force. Named “ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care“, the document discusses ways to address hurdles and effectively improve access and care in this field of medicine. ATMP therapies
European Donation Day 2024
Together, we can raise awareness and inspire action to save more lives.
#EuropeanDonationDay #ESOTaction
European Donation Day 2024 – #OneDecision
You can make a difference. By discussing your wishes with loved ones, you offer hope to those suffering from organ failure or serious health conditions. Despite the growing need, the demand for transplants still far exceeds the available supply, with thousands of patients joining waiting lists each year. Take action and help save lives today.
ESOT Mentorship Programme 2025
ESOT is strongly committed to principles of equity, fairness, and inclusion and strives to promote such values through its education programme. Members of traditionally underrepresented and marginalised groups are particularly encouraged to apply as mentors and mentees. Apply by 4 November 2024.
EACCME® Accreditation granted to International DCD Congress & Consensus
This accreditation reflects the exceptional educational value & rigorous scientific content the #DCDcongress #DCDconsensus promises to deliver.
The molecular landscape of kidney rejection
In the latest issue of Transplant International, Cortes Garcia and colleagues (France) examined bulk RNA sequencing of kidney biopsies. They identified novel genes associated with antibody-mediated rejection and T cell-mediated rejection, which could provide a new source of targets for drug design and repurposing.
ESOT Grants Programme 2025!
Why Apply for the ESOT Grants Programme?
Applying for the ESOT Grants Programme is your chance to drive innovation and make a lasting impact in transplantation.
Read what former grants recipients say.
ESOT Education Committee – Call for nominations 2024
ESOT members in good standing are welcome to apply for the position above. The new Education Committee Board Members will hold office for 3 years (2024-2027).
The application deadline is Sunday 29 September 2024.
Treating Split Livers with HOPE
In the latest issue of Transplant International, Rossignol and colleagues (Lyon, France) studied the impact of hypothermic oxygenated perfusion on ex situ split grafts (HOPE-Split) in paediatric liver transplantation. Compared with static cold storage ex situ partial grafts, HOPE-Split had significantly shorter cold ischaemia times, less post-reperfusion syndrome and a lower ischaemia-reperfusion injury score. The
